Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00021508
DRKS00021508
Completed
Not Applicable

A post market clinical follow-up study with the aneXys acetabular cup and ceramys inlay

Mathys AG Bettlach0 sites150 target enrollmentApril 24, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsM16.1M16.7Other primary coxarthrosisOther secondary coxarthrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
M16.1
Sponsor
Mathys AG Bettlach
Enrollment
150
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 24, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Informed consent form (signed by participant and investigator)
  • •\- Primary implantation
  • •\- Suffer from primary or secondary osteoarthritis of the hip, femoral head and neck fractures or necrosis of the femoral head. In all cases a stable anchoring of the implant has to be possible
  • •\- Age at inclusion: between 18 and 75 years old
  • •\- Willing to participate in the follow\-up examinations mentioned above
  • •\- Complete recovery is expected

Exclusion Criteria

  • •\- Missing informed consent form (signed by participant and investigator)
  • •\- Known or suspected non\-compliance (e.g. drug or alcohol abuse)
  • •\- Enrolment of the investigator, his/her family, employees and other dependent persons
  • •\- Patients younger 18 years old
  • •\- Revision surgery
  • •\- Presence of sepsis or malignant tumours
  • •\- ASA (American Society of Anesthesiologists) Classification \>3
  • •\- Pregnancy
  • •\- Patients not able to speak and understand the national language of the study center

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A post market clinical follow-up study with the aneXys ceramys inlay DEM16.7M16.1Other secondary coxarthrosisOther primary coxarthrosis
DRKS00018809Mathys Orthopädie GmbH150
Completed
Not Applicable
Post-market clinical follow-up study evaluating the efficacy and safety of the wearable cardioverter-defibrillator (WCD) medical device 'LifeVest' in real-life settings in France
ISRCTN91372291ZO550
Recruiting
Phase 4
Thigh bone fracture and its union by using different implants studyHealth Condition 1: O- Medical and Surgical
CTRI/2024/01/061265Auxein Medical Pvt Ltd
Completed
Phase 4
The purpose of the study is to evaluate safety and performance of Eye Preparations - HPMC EYE WASH (Hydroxy Propyl Methyl Cellulose Eye Wash )Health Condition 1: H28- Cataract in diseases classified elsewhere
CTRI/2022/07/043794STERICON PHARMA PRIVATE LIMITED72
Completed
Phase 4
A post market clinical follow up study of Sodium Hyaluronate 0.2% Eye DropsHealth Condition 1: H579- Unspecified disorder of eye and adnexa
CTRI/2024/02/062929Amanta Healthcare Limited54